| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Comments |
Department of Growth and Reproduction, The National University Hospital, Rigshospitalet, DK-2100 Copenhagen, Denmark
Address correspondence to: Katharina M. Main, M.D., Ph.D., Department of Growth and Reproduction, Section 5064, The National University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. E-mail: RH04639{at}RH.DK
Abstract
Healthy boys have a considerable production of reproductive hormones during the first postnatal months, the biological significance of which is poorly understood. We report on cases of male infants with hypogonadism (hypogonadotropic hypogonadism, n = 1; panhypopituitarism, n = 2) who showed lack of penile growth and involution of the scrotum. In two boys, diagnoses were obtained in early infancy and hormonal measurements at 3–4 months of age showed serum testosterone levels below detection limits in both low inhibin B (37 and 199 pg/mL, respectively; normal range, 193–563 pg/mL) and low to undetectable gonadotropins [LH, undetectable and 0.07 IU/L (normal range, 0.65–2.69 IU/L), respectively; FSH, 0.18 IU/L in both (range, 0.86–2.52 IU/L)]. In a third boy, gonadotropin deficiency was diagnosed at 3 yr of age by undetectable serum levels of FSH and LH both before and after stimulation with GnRH. All cases required hormonal treatment with testosterone, administered as suppositories in daily doses between 1 and 5 mg, which reintroduced male genital development. Our observations suggest that normal phallic and scrotal development in humans is dependent on intact testosterone secretion during early infancy. Additionally, the diagnosis of gonadotropin deficiency may be established in a short-time window postnatally by measurement of spontaneous serum concentrations of reproductive hormones.
IT HAS BEEN known for many years that there is a considerable pituitary and testicular hormone production with respect to gonadotropins, testosterone, dihydrotestosterone, and inhibin B in the first postnatal months of life (1, 2, 3, 4, 5, 6, 7, 8). However, the physiological and pathological significance of this peak in humans has, until now, been poorly understood.
We report on three cases of infants with male hypogonadism of different etiology who showed progressive involution of their external genitalia during early infancy despite replacement of other pituitary deficiencies. Our observations suggest that the postnatal peak in reproductive hormones plays an important role in genital development.
Materials and Methods
Serum LH and FSH were measured by time-resolved immunofluorometric assays (Delfia; Wallac, Inc., Turku, Finland) with detection limits of 0.06 and 0.05 U/L, respectively. Intra- and interassay coefficients of variation were less than 8% in both assays. Serum testosterone was measured by RIA (Coat-a-Count; Diagnostic Products, Los Angeles, CA) with a detection limit of 0.23 nmol/L and intra- and interassay coefficients of variation less than 10%. Serum inhibin B was measured by specific enzyme-linked immunosorbent assay (9) with a detection limit of 18 pg/mL, and the intra- and interassay coefficients of variations were 15% and 18%, respectively. Patient serum hormone measurements at 3–4 months of age were compared with age-specific longitudinal normal values in healthy boys (4). The normal 95% ranges were: serum testosterone, 0.43–7.71 nmol/L; inhibin B, 193–563 pg/mL; FSH, 0.86–2.52 IU/L; LH, 0.65–2.69 IU/L. Testosterone treatment was administered as suppositories of 1 or 5 mg, manufactured by the hospital’s pharmacy using a modification of the method of Hamburger (10). It is well documented that androgen replacement therapy using testosterone suppositories is effective (11).
Case reports
Case 1 (hypogonadotropic hypogonadism). This was the
fourth child of consanguinous Turkish parents. There was a maternal
history of hyposmia. The genitalia was described as normal male at
birth with descended testicles and by a pediatrician at 1 month of age.
The patient was referred at 4 months of age because of progressive
atrophy of the external genitalia. The penis consisted of a small
skinfold with practically no palpable corpora (Fig. 1a
). Both testes were inguinal, and the
scrotum was hypoplastic. The diagnosis of hypogonadotropic hypogonadism
was established as: spontaneous serum LH and testosterone were
unmeasurable, and both FSH and inhibin B were low with 0.18 IU/L and 37
pg/mL, respectively. Human CG stimulation with 100 IU/kg twice weekly
for 3 weeks increased serum testosterone to 8.01 nmol/L. Treatment with
testosterone suppositories was started at 6 months of age (1 mg twice
daily for 5 months, hereafter 5 mg daily for 5 months), showing
reasonable response (Fig. 1b).
|
Case 3 (panhypopituitarism). Case 3 was the brother to case
2. He was diagnosed with adrenal insufficiency at birth. Clinical
appearance of the external genitalia was normal at birth with both
testes in the scrotum measuring 1 mL each. Overt hypothyroidism and GH
deficiency developed at 2 and 7 months, respectively, and the patient
was substituted (daily doses: hydrocortisone, 12
mg/m2; T4, 50 µg;
recombinant human GH, 2 IU/m2 sc). From the age
of 31/2 months, the external genitalia became progressively
embedded in prepubic fat, and the testes ascended to a nonpalpable
position (Fig. 2a). Measurement of
spontaneous hormonal values showed undetectable serum testosterone, low
FSH, LH, and inhibin B with 0.18 IU/L, 0.07 IU/L, and 199 pg/mL,
respectively. Because of development of a hypoplastic scrotum and lack
of penile growth treatment with testosterone suppositories, 1 mg daily
was initiated at 9 months, followed by 1 mg twice daily from 11–14
months of age. There was a significant effect on genital development
with penile and scrotal growth and regression of the prepubic fat layer
(Fig. 2b).
|
Oral permission for publication of the figures was obtained from the parents.
Discussion
Our observations strongly suggest a significant physiological role of the postnatal peak in testosterone for genital development in newborn boys. All three patients had normal genitalia at birth but showed progressively impaired development (i.e. lack of penile growth and involution of the scrotum). In two boys it could be demonstrated that they were lacking the early physiological rise in testosterone. To our knowledge, this is the first report to document that a diagnosis of gonadotropin deficiency may be established in a short-time window postnatally, when the physiological surge of reproductive hormones should occur. The third patient was diagnosed to have gonadotropin deficiency at the age of 3 yr and was, therefore, most likely also lacking the early postnatal surge in reproductive hormones. Normal male genital development could be reestablished with administration of exogenous testosterone.
Although it has been known for a considerable number of years that reproductive hormones increase during early infancy, their biological significance has not been extensively investigated (1, 2, 3, 4, 5, 6, 7, 8). It has been a matter of debate as to whether androgens are biologically active during early infancy or not. Microphallus, as one of the symptoms of hypogonadotropic hypogonadism, has, thus, mainly been attributed to the lack of intrauterine stimulation of the fetal testes by gonadotropins during the second trimester (12). Serum concentrations of sex hormone-binding globulins increase during the same period as gonadotropins and testosterone, which may indicate that there is little free, biologically active testosterone available. According to this hypothesis, it has been shown by one group that morning salivary testosterone, representing the free fraction of testosterone, does not increase around 3 months of age in humans (13). Other investigators, however, have found an increase of free testosterone in serum (8). Our cases demonstrate for the first time that the symptoms of micropenis and maldescended testis also are associated with the lack of the early postnatal peak in reproductive hormones.
Our observations are in accordance with data from investigations of primates. A recent study of rhesus macaques indicated that at least part of the circulating testosterone is biologically active (14), because penile and clitoris growth could be significantly altered by suppressing or augmenting testosterone levels. Other intervention studies in primates, suppressing the postnatal androgen increase, have similarly been able to reproduce clinical pictures of hypogonadism (14, 15, 16), both with respect to physical maturation and to sexual behavior. The effects could, in some investigations, be followed into adult life with late onset of puberty, attenuated pubertal growth spurt, diminished testicular growth, and reduced sperm count (17, 18, 19). Recently, it was demonstrated that neonatal GnRH antagonist treatment compromised Sertoli cell replication in the marmoset (20).
There is also some evidence for a role of gonadotropins and androgens in human infant testicular development with respect to Leydig cell proliferation and germ cell differentiation (21). The penile growth rate during the early postnatal period is small, with an average of 0.17 cm/yr (12). However, this growth rate seems important to parallel the considerable increase in total body length during the same period. In all our patients, the external genitalia responded to androgen treatment with significant growth of the penis and scrotum.
In conclusion, our observations support the hypothesis that the postnatal surge in pituitary and testicular hormone secretion in human infants has a significant biological role in the normal development of the male genitalia. Thus, symptoms of hypogonadism are not only related to the lack of hormone production in utero or during puberty. Our observations may be clinically applicable for diagnosing gonadotropin and/or androgen deficiency in patients with genital maldevelopment by early postnatal measurement of spontaneous serum concentrations of reproductive hormones. It remains to be seen whether or not the early effects on genital growth and development are also of significance for adult reproductive function.
Received April 19, 2000.
Revised June 26, 2000.
Revised August 24, 2000.
Revised September 7, 2000.
Accepted September 7, 2000.
References
This article has been cited by other articles:
 |
|
 |
|
  H.E. Virtanen and J. Toppari Epidemiology and pathogenesis of cryptorchidism Hum. Reprod. Update, January 1, 2008; 14(1): 49 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Aksglaede, J. H Petersen, K. M Main, N. E Skakkebaek, and A. Juul High normal testosterone levels in infants with non-mosaic Klinefelter's syndrome Eur. J. Endocrinol., September 1, 2007; 157(3): 345 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Mau Kai, K. M. Main, A. N. Andersen, A. Loft, N. E. Skakkebaek, and A. Juul Reduced Serum Testosterone Levels in Infant Boys Conceived by Intracytoplasmic Sperm Injection J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2598 - 2603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. van Tijn, E. J. Schroor, H. A. Delemarre-van de Waal, J. J. M. de Vijlder, and T. Vulsma Early Assessment of Hypothalamic-Pituitary-Gonadal Function in Patients with Congenital Hypothyroidism of Central Origin J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 104 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M Main, J. Toppari, and N. E Skakkebaek Gonadal development and reproductive hormones in infant boys Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S51 - S57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Boas, K. A Boisen, H. E Virtanen, M. Kaleva, A.-M. Suomi, I. M Schmidt, I. N Damgaard, C. M Kai, M. Chellakooty, N. E Skakkebaek, et al. Postnatal penile length and growth rate correlate to serum testosterone levels: a longitudinal study of 1962 normal boys Eur. J. Endocrinol., January 1, 2006; 154(1): 125 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. van Tijn, J. J. M. de Vijlder, B. Verbeeten Jr., P. H. Verkerk, and T. Vulsma Neonatal Detection of Congenital Hypothyroidism of Central Origin J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3350 - 3359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chellakooty, I. M. Schmidt, A. M. Haavisto, K. A. Boisen, I. N. Damgaard, C. Mau, J. H. Petersen, A. Juul, N. E. Skakkebaek, and K. M. Main Inhibin A, Inhibin B, Follicle-Stimulating Hormone, Luteinizing Hormone, Estradiol, and Sex Hormone-Binding Globulin Levels in 473 Healthy Infant Girls J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3515 - 3520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Raivio, J. Toppari, M. Kaleva, H. Virtanen, A.-M. Haavisto, L. Dunkel, and O. A. Janne Serum Androgen Bioactivity in Cryptorchid and Noncryptorchid Boys during the Postnatal Reproductive Hormone Surge J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2597 - 2599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Buzzard, P. G. Farnworth, D. M. de Kretser, A. E. O'Connor, N. G. Wreford, and J. R. Morrison Proliferative Phase Sertoli Cells Display a Developmentally Regulated Response to Activin in Vitro Endocrinology, February 1, 2003; 144(2): 474 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Laurich, A. M. Trbovich, F. H. O'Neill, C. P. Houk, P. M. Sluss, A. H. Payne, P. K. Donahoe, and J. Teixeira Mullerian Inhibiting Substance Blocks the Protein Kinase A-Induced Expression of Cytochrome P450 17{alpha}-Hydroxylase/C17-20 Lyase mRNA in a Mouse Leydig Cell Line Independent of cAMP Responsive Element Binding Protein Phosphorylation Endocrinology, September 1, 2002; 143(9): 3351 - 3360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Quigley The Postnatal Gonadotropin and Sex Steroid Surge--Insights from the Androgen Insensitivity Syndrome J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 24 - 28. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
